Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1994-6-27
pubmed:abstractText
Western blot analysis proved that all cluster-2 MAbs recognize identical or overlapping disulfide-bond-dependent epitopes, indicating the presence of a disulfide-bond-stabilized EGP-2 domain carrying highly immunodominant non-linear epitopes. The apparent immunodominance of this domain makes it difficult to generate and select antibodies against other potentially useful EGP-2 epitopes. Using PCR, we have generated mutant EGP-2 cDNA (delta EGP-2) from which the coding sequences for a putative immunodominant 6-kDa intra-chain loop structure has been removed. delta EGP-2 transfected COS-7 cells reacted with MM104, an antibody detecting a linear epitope on EGP-2, but were not recognized by any cluster-2 MAb. To generate new anti-EGP-2 antibodies we constructed another mutant EGP-2 protein (delta EGP-2) from which additional domains, irrelevant for antibody generation (signal peptide, trans-membrane and cytoplasmic domains), were removed. delta EGP-2 was introduced in a prokaryotic expression system that adds a polyhistidine affinity tag to the delta EGP-2 N-terminus, making possible one-step purification by immobilized metal-ion-affinity chromatography (IMAC). Western blot analysis showed that sera derived from mice immunized with purified delta EGP-2 had high-titer antibodies to reduced EGP-2 samples. We conclude that the availability of prokaryotic and eukaryotic EGP-2-expression constructs might facilitate the selection of new anti-EGP-2 MAbs otherwise difficult to obtain.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0898-6924
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
64-9
pubmed:dateRevised
2007-7-23
pubmed:meshHeading
pubmed-meshheading:7515032-Amino Acid Sequence, pubmed-meshheading:7515032-Animals, pubmed-meshheading:7515032-Antibodies, Monoclonal, pubmed-meshheading:7515032-Antigens, Neoplasm, pubmed-meshheading:7515032-Base Sequence, pubmed-meshheading:7515032-Blotting, Western, pubmed-meshheading:7515032-Carcinoma, Small Cell, pubmed-meshheading:7515032-Cell Adhesion Molecules, pubmed-meshheading:7515032-Cell Line, pubmed-meshheading:7515032-Cercopithecus aethiops, pubmed-meshheading:7515032-DNA, Complementary, pubmed-meshheading:7515032-DNA Primers, pubmed-meshheading:7515032-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:7515032-Epitopes, pubmed-meshheading:7515032-Humans, pubmed-meshheading:7515032-Lung Neoplasms, pubmed-meshheading:7515032-Molecular Sequence Data, pubmed-meshheading:7515032-Polymerase Chain Reaction, pubmed-meshheading:7515032-Restriction Mapping, pubmed-meshheading:7515032-Transfection, pubmed-meshheading:7515032-Tumor Cells, Cultured, pubmed-meshheading:7515032-Tumor Markers, Biological
pubmed:year
1994
pubmed:articleTitle
Epitope mapping of SCLC-cluster-2 MAbs and generation of antibodies directed against new EGP-2 epitopes.
pubmed:affiliation
Department of Clinical Immunology, University Hospital Groningen, The Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't